Changes in liver-related mortality by etiology and sequelae: underlying versus multiple causes of death
Tóm tắt
The expanded definition of liver-related deaths includes a wide range of etiologies and sequelae. We compared the changes in liver-related mortality by etiology and sequelae for different age groups between 2008 and 2018 in the USA using both underlying and multiple cause of death (UCOD and MCOD) data. We extracted mortality data from the CDC WONDER. Both the absolute (rate difference) and relative (rate ratio and 95% confidence intervals) changes were calculated to quantify the magnitude of change using the expanded definition of liver-related mortality. Using the expanded definition including secondary liver cancer and according to UCOD data, we identified 68,037 liver-related deaths among people aged 20 years and above in 2008 (29 per 100,000) and this increased to 90,635 in 2018 (33 per 100,000), a 13% increase from 2008 to 2018. However, according to MCOD data, the number of deaths was 113,219 (48 per 100,000) in 2008 and increased to 161,312 (58 per 100,000) in 2018, indicating a 20% increase. The increase according to MCOD was mainly due to increase in alcoholic liver disease and secondary liver cancer (liver metastasis) for each age group and hepatitis C virus (HCV) and primary liver cancer among decedents aged 65–74 years. The direction of mortality change (increasing or decreasing) was similar in UCOD and MCOD data in most etiologies and sequelae, except secondary liver cancer. However, the extent of change differed between UCOD and MCOD data.
Tài liệu tham khảo
Kim ER. The burden of hepatitis C in the United States. Hepatology. 2002;36(5 Suppl 1):S30–4. https://doi.org/10.1053/jhep.2002.36791.
Wise M, Bialek S, Finelli L, Bell BP, Sorvillo F. Changing trends in hepatitis C-related mortality in the United States, 1995-2004. Hepatology. 2008;47(4):1128–35. https://doi.org/10.1002/hep.22165.
Ly KN, Hughes EM, Jiles RB, Holmberg SD. Rising mortality associated with hepatitis C virus in the United States, 2003–2013. Clin Infect Dis. 2016;62(10):1287–8. https://doi.org/10.1093/cid/ciw111.
Ly KN, Minino AM, Liu SJ, et al. Deaths associated with hepatitis C virus infection among residents in 50 States and the District of Columbia, 2016–2017. Clin Infect Dis. 2020;71(5):1149–60. https://doi.org/10.1093/cid/ciz976.
Ly KN, Xing J, Klevens RM, Jiles RB, Ward JW, Holmberg SD. The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. Ann Intern Med. 2012;156(4):271–8. https://doi.org/10.7326/0003-4819-156-4-201202210-00004.
Mendes FD, Kim WR, Pedersen R, Therneau T, Lindor KD. Mortality attributable to cholestatic liver disease in the United States. Hepatology. 2008;47(4):1241–7. https://doi.org/10.1002/hep.22178.
Paula H, Asrani SK, Boetticher NC, et al. Alcoholic liver disease-related mortality in the United States: 1980-2003. Am J Gastroenterol. 2010;105:1782–7.
Moon AM, Yang JY, Barritt AS IV, et al. Rising mortality from alcohol-associated liver disease in the United States in the 21st century. Am J Gastroenterol. 2020;115(1):79–87. https://doi.org/10.14309/ajg.0000000000000442.
Paik JM, Henry L, De Avila L, et al. Mortality related to nonalcoholic fatty liver disease is increasing in the United States. Hepatol Commun. 2019;3(11):1459–71. https://doi.org/10.1002/hep4.1419.
Altekruse SF, Henley SJ, Cucinelli JE, et al. Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States. Am J Gastroenterol. 2014;109(4):542–53. https://doi.org/10.1038/ajg.2014.11.
Kim D, Li AA, Gadiparthi C, Khan MA, Cholankeril G, Glenn JS, et al. Changing trends in etiology-based annual mortality from chronic liver disease from 2007 through 2016. Gastroenterology. 2018;155(4):1154–63. https://doi.org/10.1053/j.gastro.2018.07.008.
Tapper EB, Parikh ND. Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study. BMJ. 2018;362:k2817.
Kim D, Li AA, Perumpail BJ, Gadiparthi C, Kim W, Cholankeril G, et al. Changing trends in etiology-based and ethnicity-based annual mortality rates of cirrhosis and hepatocellular carcinoma in the United States. Hepatology. 2019;69(3):1064–74. https://doi.org/10.1002/hep.30161.
Kim WR, Brown RS Jr, Terrault NA, El-Serag H. Burden of liver disease in the United States: summary of a workshop. Hepatology. 2002;36(1):227–42. https://doi.org/10.1053/jhep.2002.34734.
Vong S, Bell BP. Chronic liver disease mortality in the United States, 1990-1998. Hepatology. 2004;39(2):476–83. https://doi.org/10.1002/hep.20049.
Manos MM, Leyden WA, Murphy RC, Terrault NA, Bell BP. Limitations of conventionally derived chronic liver disease mortality rates: results of a comprehensive assessment. Hepatology. 2008;47(4):1150–7. https://doi.org/10.1002/hep.22181.
Asrani SK, Larson JJ, Yawn B, et al. Underestimation of liver-related mortality in the United States. Gastroenterology. 2013;145:375–82.e1–2.
Ly KN, Speers S, Klevens RM, Barry V, Vogt TM. Measuring chronic liver disease mortality using an expanded cause of death definition and medical records in Connecticut, 2004. Hepatol Res. 2015;45(9):960–8. https://doi.org/10.1111/hepr.12437.
Fedeli U, Schievano E, Lisiero M, Avossa F, Mastrangelo G, Saugo M. Descriptive epidemiology of chronic liver disease in northeastern Italy: an analysis of multiple causes of death. Popul Health Metrics. 2013;11(1):20. https://doi.org/10.1186/1478-7954-11-20.
World Health Organization. ICD-10: International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Volume 2 Instruction Manual, Fifth Edition, 2016. Geneva: World Health Organization; 2016. Available from: https://icd.who.int/browse10/Content/statichtml/ICD10Volume2_en_2016.pdf
Israel RA, Rosenberg HM, Curtin LR. Analytical potential for multiple cause-of-death data. Am J Epidemiol. 1986;124(2):161–79. https://doi.org/10.1093/oxfordjournals.aje.a114375.
Goldacre MJ. Cause-specific mortality: understanding uncertain tips of the disease iceberg. J Epidemiol Community Health. 1993;47(6):491–6. https://doi.org/10.1136/jech.47.6.491.
Redelings MD, Sorvillo F, Simon P. A comparison of underlying cause and multiple causes of death: US vital statistics, 2000–2001. Epidemiology. 2006;17(1):100–3. https://doi.org/10.1097/01.ede.0000187177.96138.c6.
Fedeli U, Avossa F, Guzzinati S, Bovo E, Saugo M. Trends in mortality from chronic liver disease. Ann Epidemiol. 2014;24(7):522–6. https://doi.org/10.1016/j.annepidem.2014.05.004.
Desequelles A, Demuru E, Egidi V, et al. Cause-specific morality analysis: in the underlying cause of death sufficient? Quetelet J. 2014;2(1):119–35. https://doi.org/10.14428/rqj2014.02.01.05.
Piffaretti C, Moreno-Betancur M, Lamarche-Vadel A, Rey G. Quantifying cause-related mortality by weighting multiple causes of death. Bull World Health Organ. 2016;94(12):870–9. https://doi.org/10.2471/BLT.16.172189.
Fedeli U, Grande E, Grippo F, Frova L. Mortality associated with hepatitis C and hepatitis B virus infection: a nationwide study on multiple causes of death data. World J Gastroenterol. 2017;23(10):1866–71. https://doi.org/10.3748/wjg.v23.i10.1866.
Batty GD, Gale CR, Kivimäki M, Bell S. Assessment of relative utility of underlying vs contributory causes of death. JAMA Netw Open. 2019;2(7):e198024. https://doi.org/10.1001/jamanetworkopen.2019.8024.
Cardona K, Maithel SK, editors. Primary and metastatic liver tumors: treatment strategy and evolving therapies. Switzerland: Springer Nature; 2018. https://doi.org/10.1007/978-3-319-91977-5.
Mahvi DA, Mahvi DM. Liver Metastases. In: Niederhuber JE, editor. Abeloff's Clinical Oncology, the Six Edition. Philadelphia: Elsevier, Inc; 2020. p. 846–62.
Center for Disease Control and Prevention. Wide-ranging ONline Data for Epidemiologic Research (CDC WONDER): multiple cause of death data. https://wonder.cdc.gov/mcd.html Accessed at 4 Apr 2020.
Pinheiro PS, Callahan KE, Jones PD, Morris C, Ransdell JM, Kwon D, et al. Liver cancer: a leading cause of cancer death in the United States and the role of the 1945–1965 birth cohort by ethnicity. JHEP Rep. 2019;1(3):162–9. https://doi.org/10.1016/j.jhepr.2019.05.008.
Zheng Z, Chen C, Jiang L, Zhou X, Dai X, Song Y, et al. Incidence and risk factors of gastrointestinal neuroendocrine neoplasm metastasis in liver, lung, bone, and brain: a population-based study. Cancer Med. 2019;8(17):7288–98. https://doi.org/10.1002/cam4.2567.
Xie J, Xu Z. A population-based study on liver metastases in women with newly diagnosed breast cancer. Cancer Epidemiol Biomark Prev. 2019;28(2):283–92. https://doi.org/10.1158/1055-9965.EPI-18-0591.
Siebenhüner AR, Güller U, Warschkow R. Population-based SEER analysis of survival in colorectal cancer patients with or without resection of lung and liver metastases. BMC Cancer. 2020;20:1–9.
Smith BD, Morgan RL, Beckett GA, Falck-Ytter Y, Holtzman D, Teo CG, et al. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. MMWR Recomm Rep. 2012;61(RR-4):1–32.